within Pharmacolibrary.Drugs.ATC.J;

model J02AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.015,
    Cl             = 0.0001933333333333333,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J02AB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Miconazole is an imidazole antifungal drug commonly used in the treatment of fungal infections, such as candidiasis of the skin, mouth, and vagina. It works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Miconazole is approved for clinical use and is available in topical, oral, and intravenous formulations, though oral and intravenous usage is less common due to poor systemic absorption and adverse effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single oral dose administration.</p><h4>References</h4><ol><li><p>Hynninen, VV, et al., &amp; Laine, K (2009). Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. <i>European journal of clinical pharmacology</i> 65(1) 89–95. DOI:<a href=\"https://doi.org/10.1007/s00228-008-0556-9\">10.1007/s00228-008-0556-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18777173/\">https://pubmed.ncbi.nlm.nih.gov/18777173</a></p></li><li><p>Grönlund, J, et al., &amp; Laine, K (2011). Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4. <i>Antimicrobial agents and chemotherapy</i> 55(3) 1063–1067. DOI:<a href=\"https://doi.org/10.1128/AAC.01242-10\">10.1128/AAC.01242-10</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21173180/\">https://pubmed.ncbi.nlm.nih.gov/21173180</a></p></li><li><p>Cardot, JM, et al., &amp; Aiache, JM (2004). Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. <i>British journal of clinical pharmacology</i> 58(4) 345–351. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.2004.02154.x\">10.1111/j.1365-2125.2004.02154.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15373926/\">https://pubmed.ncbi.nlm.nih.gov/15373926</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J02AB01;
